Will Congress Authorize Cannabis Research?

Both sides in Congress are interested in cannabis research.  Will it actually happen?

A bipartisan coalition of House and Senate lawmakers have proposed legislation, the Medical Marijuana Research Act of 2016 and the Marijuana Effective Drug Studies Act, to facilitate and accelerate clinical investigations into the safety and efficacy of cannabis.

Passage of the measures – House Bill 5549 and Senate Bill 3077 – would expedite the federal review process for clinical protocols involving cannabis. It would also eliminate existing production limits for research grade cannabis and allow for investigators to access the plant from sources other than the federal government’s sole licensed cultivation facility located at the University of Mississippi. It also mandates an FDA review of relevant cannabis studies to be performed within five years after the act’s passage.

Under present law, clinical investigations involving cannabis must meet approval from various federal agencies, including the US Drug Enforcement Administration, the Food and Drug Administration, and the US National Institute on Drug Abuse. Only cannabis provided by NIDA/U-Miss program may be used in clinical trials. No other controlled substance, including other schedule I controlled substances, face such restrictions.

There is more to this report and links to the two bills HERE.

[image:  aoc.gov]

Featured Partner: Meet All Your Local Marijuana Needs (Buy Sell Buds) Anonymously In Real-Time For FREE

Leafedin – Weed App – Find Weed Near You! Meet Any of Your Marijuana Product or Labor Needs Locally in Real-Time! Free Anonymous Map Weed App, Works On Any Device, Sign-Up In Seconds and Find Bud Connects Marijuana Work or Labor, New Clients, etc INSTANTLY!


Author: DavidB

a heathen, but hopefully not an unenlightened one

Share This Post On

Pin It on Pinterest

Share This